BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31819034)

  • 21. Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.
    Cannito S; Turato C; Paternostro C; Biasiolo A; Colombatto S; Cambieri I; Quarta S; Novo E; Morello E; Villano G; Fasolato S; Musso T; David E; Tusa I; Rovida E; Autelli R; Smedile A; Cillo U; Pontisso P; Parola M
    Oncotarget; 2015 Feb; 6(4):2206-21. PubMed ID: 25544768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial UQCC3 Modulates Hypoxia Adaptation by Orchestrating OXPHOS and Glycolysis in Hepatocellular Carcinoma.
    Yang Y; Zhang G; Guo F; Li Q; Luo H; Shu Y; Shen Y; Gan J; Xu L; Yang H
    Cell Rep; 2020 Nov; 33(5):108340. PubMed ID: 33147459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
    FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans.
    Kim Y; Jang M; Lim S; Won H; Yoon KS; Park JH; Kim HJ; Kim BH; Park WS; Ha J; Kim SS
    Hepatology; 2011 Nov; 54(5):1661-78. PubMed ID: 21748762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of HIF-2α on regulating CDCP1 to promote hepatocellular carcinoma metastasis].
    Cao MQ; Gao JR; Huang JF; You AB; Guo ZG; Zhou HY; Fang F; Zhang W; Zhu XL; Zhang T
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):18-23. PubMed ID: 28104028
    [No Abstract]   [Full Text] [Related]  

  • 26. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop.
    Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL
    Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate.
    Diez H; Fischer A; Winkler A; Hu CJ; Hatzopoulos AK; Breier G; Gessler M
    Exp Cell Res; 2007 Jan; 313(1):1-9. PubMed ID: 17045587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1α protein under hypoxic conditions.
    Laemmle A; Lechleiter A; Roh V; Schwarz C; Portmann S; Furer C; Keogh A; Tschan MP; Candinas D; Vorburger SA; Stroka D
    PLoS One; 2012; 7(3):e33433. PubMed ID: 22479397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
    Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
    Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of hypoxia-signaling pathways by extracellular linc-RoR.
    Takahashi K; Yan IK; Haga H; Patel T
    J Cell Sci; 2014 Apr; 127(Pt 7):1585-94. PubMed ID: 24463816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
    Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
    Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia induces copper stable isotope fractionation in hepatocellular carcinoma, in a HIF-independent manner.
    Bondanese VP; Lamboux A; Simon M; Lafont JE; Albalat E; Pichat S; Vanacker JM; Telouk P; Balter V; Oger P; Albarède F
    Metallomics; 2016 Nov; 8(11):1177-1184. PubMed ID: 27500357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
    Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
    Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expressions of hepatitis B virus x protein and hypoxia-inducible factor-1alpha in hepatocellular carcinoma and their possible relationships].
    Liu KG; Xie HH; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):122-6. PubMed ID: 17362638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stable knockdown of CREB, HIF-1 and HIF-2 by replication-competent retroviruses abrogates the responses to hypoxia in hepatocellular carcinoma.
    Shneor D; Folberg R; Pe'er J; Honigman A; Frenkel S
    Cancer Gene Ther; 2017 Feb; 24(2):64-74. PubMed ID: 27934882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
    PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.
    Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K
    Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JAG2 induction in hypoxic tumor cells alters Notch signaling and enhances endothelial cell tube formation.
    Pietras A; von Stedingk K; Lindgren D; Påhlman S; Axelson H
    Mol Cancer Res; 2011 May; 9(5):626-36. PubMed ID: 21402725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APC
    Shi M; Dai WQ; Jia RR; Zhang QH; Wei J; Wang YG; Xiang SH; Liu B; Xu L
    Cancer Lett; 2021 Jan; 496():144-155. PubMed ID: 33039559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.